Insights into cellular uptake of nanoparticles

Current Drug Delivery

Volumn 12, Issue 1, 2015, Pages 63-77

  Kafshgari, Morteza Hasanzadeh ^a   Harding, Frances J ^a   Voelcker, Nicolas H ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Endocytosis; Nanomedicine; Nanoparticles; Subcellular targeting

Indexed keywords

CLATHRIN; NANOCARRIER; NANOMATERIAL; NANOPARTICLE; DRUG; DRUG CARRIER;

ARTICLE; CAVEOLA; CELL MIGRATION; CELL NUCLEUS; CYTOPLASM; CYTOSOL; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; HUMAN; NONHUMAN; PHAGOCYTOSIS; PINOCYTOSIS; PRIORITY JOURNAL; ACTIVE TRANSPORT; ANIMAL; CHEMISTRY; MEDICINAL CHEMISTRY; METABOLISM; NANOMEDICINE; PHARMACEUTICS; PROCEDURES; TRANSPORT AT THE CELLULAR LEVEL;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BIOLOGICAL TRANSPORT; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; HUMANS; NANOMEDICINE; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS; TECHNOLOGY, PHARMACEUTICAL;

EID: 84930902333     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/1567201811666140821110631     Document Type: Article

References (201)

1. Bareford, L. M.; Swaan, P. W. Endocytic mechanisms for targeted drug delivery. Adv. Drug Deliv. Rev., 2007, 59, 748-758.
2. Khalil, I. A.; Kogure, K.; Akita, H.; Harashima, H. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol. Rev., 2006, 58, 32-45.
3. Ziello, J. E.; Huang, Y.; Jovin, I. S. Cellular endocytosis and gene delivery. Mol. Med., 2000, 16, 222-229.
4. Hillaireau, H.; Couvreur, P. Nanocarriers' entry into the cell: relevance to drug delivery. Cell. Mol. Life Sci., 2009, 66, 2873-2896.
5. May, R.; Machesky, L. Phagocytosis and the actin cytoskeleton. J. Cell Sci., 2001, 114, 1061-1077.
6. Sahay, G.; Alakhova, D.; Kabanov, A. Endocytosis of nanomedicines. J. Control. Release, 2010, 145, 182-95.
7. Norbury, C. C. Drinking a lot is good for dendritic cells. Immunology 2006, 117, 443-451.
8. Groves, E.; Dart, A.; Covarelli, V.; Caron, E. Molecular mechanisms of phagocytic uptake in mammalian cells. Cell Mol. Life Sci., 2008, 65, 1957-76.
9. Dramsi, S.; Cossart, P. Intracellular pathogens and the actin cytoskeleton. Annu. Rev. Cell Dev. Biol., 1998, 14, 137-166.
10. Aderem, A.; Underhill, D. M. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 1999, 17, 593-623.
11. Coppolino, M. G.; Krause, M.; Hagendorff, P.; Monner, D. A.; Trimble, W.; Grinstein, S.; Wehland, J.; Sechi, A. S. Evidence for a molecular complex consisting of Fyb/SLAP, SLP-76, Nck, VASP and WASP that links the actin cytoskeleton to Fcγ receptor signalling during phagocytosis. J. Cell Sci., 2001, 114, 4307-4318.
12. Champion, J. A.; Mitragotri, S. Role of target geometry in phagocytosis. Proc. Natl. Acad. Sci. U. S. A., 2006, 103, 4930-4934.
13. Champion, J. A.; Katare, Y. K.; Mitragotri, S. Making polymeric micro-and nanoparticles of complex shapes. Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 11901-11904.
14. Iversen, T.-G.; Skotland, T.; Sandvig, K. Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies. Nano Today, 2011, 6, 176-185.
15. McMahon, H.; Boucrot, E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol., 2011, 12, 517-533.
16. Lakadamyali, M.; Rust, M. J.; Zhuang, X. Ligands for clathrinmediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell 2006, 124, 997-1009.
17. Godlee, C.; Kaksonen, M. From uncertain beginnings: Initiation mechanisms of clathrin-mediated endocytosis. J. Cell Biol., 2013, 203, 717-725.
18. Cocucci, E.; Aguet, F.; Boulant, S.; Kirchhausen, T. The first five seconds in the life of a clathrin-coated pit. Cell, 2012, 150, 495-507.
19. Mousavi, S. A.; Malerod, L.; Berg, T.; Kjeken, R. Clathrindependent endocytosis. Biochem. J., 2004, 377, 1-16.
20. Munoz, A.; Costa, M. Elucidating the mechanisms of nickel compound uptake: A review of particulate and nano-nickel endocytosis and toxicity. Toxicol. Appl. Pharmacol., 2012, 260, 1-16.
21. Watson, P.; Jones, A. T.; Stephens, D. J. Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells. Adv. Drug Deliv. Rev. 2005, 57, 43-61.
22. Traub, L. Clathrin couture: fashioning distinctive membrane coats at the cell surface. PLoS Biol., 2009, 7, e1000192.
23. Tran, N.; Webster, T. J. Understanding magnetic nanoparticle osteoblast receptor-mediated endocytosis using experiments and modeling. Nanotechnology, 2013, 24, 185102.
24. Pelkmans, L.; Helenius, A. Endocytosis via caveolae. Traffic, 2002, 3, 311-320.
25. Byrne, D. P.; Dart, C.; Rigden, D. J. Evaluating caveolin interactions: Do proteins interact with the caveolin scaffolding domain through a widespread aromatic residue-rich motif? PLoS ONE, 2012, 7, e44879.
26. Couet, J.; Li, S.; Okamoto, T.; Ikezu, T.; Lisanti, M. Identification of peptide and protein ligands for the caveolin-scaffolding domain-Implications for the interaction of caveolin with caveolaeassociated proteins. J. Biol. Chem., 1997, 272, 6525-6533.
27. Sverdlov, M.; Shajahan, A.; Minshall, R. Tyrosine phosphorylation-dependence of caveolae-mediated endocytosis. J. Cell Mol. Med., 2007, 11, 1239-1250.
28. Couet, J.; Sargiacomo, M.; Lisanti, M. P. Interaction of a Receptor Tyrosine Kinase, EGF-R, with Caveolins caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem., 1997, 272, 30429-30438.
29. Kiss, A. Caveolae and the Regulation of Endocytosis. In Caveolins and Caveolae, Jasmin, J.-F.; Frank, P.; Lisanti, M., Eds. Springer US: 2012; Vol. 729, pp 14-28.
30. Pelkmans, L.; Puntener, D.; Helenius, A. Local actin polymerization and dynamin recruitment in sv40-induced internalization of caveolae. Science, 2002, 296, 535-539.
31. Branza-Nichita, N.; Macovei, A.; Lazar, C.; In: Molecular Regulation of Endocytosis; Ceresa B., Ed.; Intech; 2012, 155-182.
32. Pelkmans, L.; Kartenbeck, J.; Helenius, A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol., 2001, 3, 473-483.
33. Hayer, A.; Stoeber, M.; Ritz, D.; Engel, S.; Meyer, H. H.; Helenius, A. Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation. J. Cell Biol., 2010, 191, 615-629.
34. Prosser, D. C.; Wendland, B. Conserved roles for yeast Rho1 and mammalian RhoA GTPases in clathrin-independent endocytosis. Small GTPases, 2012, 3, 229-235.
35. Doherty, G. J.; McMahon, H. T. Mechanisms of endocytosis. Annu. Rev. Biochem., 2009, 78, 857-902.
36. Hansen, C. G.; Nichols, B. J., Molecular mechanisms of clathrinindependent endocytosis. J. Cell Sci., 2009, 122, 1713-1721.
37. Koivusalo, M.; Welch, C.; Hayashi, H.; Scott, C. C.; Kim, M.; Alexander, T.; Touret, N.; Hahn, K. M.; Grinstein, S., Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J. Cell Biol., 2010, 188, 547-563.
38. Izumi, G.; Sakisaka, T.; Baba, T.; Tanaka, S.; Morimoto, K.; Takai, Y. Endocytosis of E-cadherin regulated by Rac and Cdc42 small G proteins through IQGAP1 and actin filaments. J. Cell Biol., 2004 166, 237-248.
39. Wittrup, A.; Zhang, S.-H.; Svensson, K. J.; Kucharzewska, P.; Johansson, M. C.; Morgelin, M.; Belting, M. Magnetic nanoparticle-based isolation of endocytic vesicles reveals a role of the heat shock protein GRP75 in macromolecular delivery. Proc. Natl. Acad. Sci. U. S. A., 2010, 107, 13342-13347.
40. Jones, A. T. Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides. J. Cell. Mol. Med., 2007, 11, 670-684.
41. Kerr, M.; Teasdale, R., Defining macropinocytosis. Traffic, 2009, 10, 364-371.
42. Swanson, J. A. Shaping cups into phagosomes and macropinosomes. Nat. Rev. Mol. Cell Biol., 2008, 9, 639-649.
43. Luhmann, T.; Rimann, M.; Bittermann, A. G.; Hall, H. Cellular uptake and intracellular pathways of PLL-g-PEG-DNA nanoparticles. Bioconj. Chem., 2008, 19, 1907-1916.
44. Weissleder, R.; Nahrendorf, M.; Pittet, M. J. Imaging macrophages with nanoparticles. Nat. Mater., 2014, 13, 125-138.
45. Bacallao, R.; Garfinkel, A.; Monke, S.; Zampighi, G.; Mandel, L. J. ATP depletion: a novel method to study junctional properties in epithelial tissues. J. Cell Sci., 1994, 107, 3301-3313.
46. Lieberthal, W.; Menza, S. A.; Levine, J. S. Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. Am. J. Physiol. Renal Physiol., 1998, 274 (2), F315-F327.
47. Huang, M.; Ma, Z.; Khor, E.; Lim, L.-Y. Uptake of FITC-chitosan nanoparticles by A549 Cells. Pharm. Res., 2002, 19, 1488-1494.
48. Sakurai, T.; Itoh, K.; Liu, Y.; Higashitsuji, H.; Sumitomo, Y.; Sakamaki, K.; Fujita, J. Low temperature protects mammalian cells from apoptosis initiated by various stimuli in vitro. Exp. Cell. Res. 2005, 309, 264-272.
49. Kroemer, G.; Reed, J. Mitochondrial control of cell death. Nat. Med., 2000, 6, 513-519.
50. Shibata, M.; Hattori, H.; Sasaki, T.; Gotoh, J.; Hamada, J.; Fukuuchi, Y. Activation of caspase-12 by endoplasmic reticulum stress induced by transient middle cerebral artery occlusion in mice. Neuroscience, 2003, 118, 491-499.
51. Chia, P. Z. C.; Gleeson, P. A. Imaging and quantitation techniques for tracking cargo along endosome-to-golgi transport pathways. Cells, 2013, 2, 105-123.
52. Kam, N. W. S.; Liu, Z.; Dai, H. Carbon nanotubes as intracellular transporters for proteins and DNA: An investigation of the uptake mechanism and pathway. Angew. Chem. Int. Ed., 2006, 45, 577-581.
53. Larkin, J. M.; Brown, M. S.; Goldstein, J. L.; Anderson, R. G. W., Depletion of intracellular potassium arrests coated pit formation and receptor-mediated endocytosis in fibroblasts. Cell, 1983, 33, 273-285.
54. Gratton, S. E. A.; Ropp, P. A.; Pohlhaus, P. D.; Luft, J. C.; Madden, V. J.; Napier, M. E.; DeSimone, J. M. The effect of particle design on cellular internalization pathways. Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 11613-11618.
55. Macia, E.; Ehrlich, M.; Massol, R.; Boucrot, E.; Brunner, C.; Kirchhausen, T. Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell, 2006, 10, 839-850.
56. Pichler, H.; Riezman, H. Where sterols are required for endocytosis. Biochim. Biophys. Acta, 2004, 1666, 51-61.
57. Bolard, J. How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim. Biophys. Acta Rev. Biomembr., 1986, 864 (3-4), 257-304.
58. Le, P. U.; Nabi, I. R. Distinct caveolae-mediated endocytic pathways target the Golgi apparatus and the endoplasmic reticulum. J. Cell Sci., 2003, 116, 1059-1071.
59. Fujimoto, L. M.; Roth, R.; Heuser, J. E.; Schmid, S. L. Actin assembly plays a variable, but not obligatory role in receptormediated endocytosis. Traffic, 2000, 1, 161-171.
60. Eilers, U.; Klumperman, J.; Hauri, H.-P. Nocodazole, a microtubuleactive drug, interferes with apical protein delivery in cultured intestinal epithelial cells (Caco-2). J. Cell Biol., 1989, 108, 13-22.
61. Christiansen, J. J.; Weimbs, T.; Bander, N.; Rajasekaran, A. K. Differing effects of microtubule depolymerizing and stabilizing chemotherapeutic agents on t-SNARE-mediated apical targeting of prostate-specific membrane antigen. Mol. Cancer Ther., 2006, 5, 2468-2473.
62. Sarkar, K.; Kruhlak, M. J.; Erlandsen, S. L.; Shaw, S. Selective inhibition by rottlerin of macropinocytosis in monocyte-derived dendritic cells. Immunology, 2005, 116, 513-524.
63. Vercauteren, D.; Vandenbroucke, R. E.; Jones, A. T.; Rejman, J.; Demeester, J.; Smedt, S. C. D.; Sanders, N. N.; Braeckmans, K. The use of inhibitors to study endocytic pathways of gene carriers: Optimization and pitfalls. Mol. Ther., 2010, 18 (3), 561-569.
64. Douglas, K.; Piccirillo, C.; Tabrizian, M. Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors. Eur. J. Pharm. Biopharm., 2008, 68, 676-687.
65. Snijder, B.; Sacher, R.; Ramo, P.; Damm, E.; Liberali, P.; Pelkmans, L. Population context determines cell-to-cell variability in endocytosis and virus infection. Nature, 2009, 461, 520-523.
66. Vranic, S.; Boggetto, N.; Contremoulins, V.; Mornet, S.; Reinhardt, N.; Marano, F.; Baeza-Squiban, A.; Boland, S. Deciphering the mechanisms of cellular uptake of engineered nanoparticles by accurate evaluation of internalization using imaging flow cytometry. Part. Fibre Toxicol., 2013, 10, 2.
67. Agnello, V.; Abel, G.; Elfahal, M.; Knight, G. B.; Zhang, Q.-X. Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. U. S. A., 1999, 96 (22), 12766-12771.
68. Pol, A.; Lu, A.; Pons, M.; Peiro, S.; Enrich, C. Epidermal growth factor-mediated caveolin recruitment to early endosomes and mapk activation. Role of cholesterol and actin cytoskeleton. J. Biol. Chem., 2000, 275, 30566-30572.
69. Ivanov, A. Pharmacological inhibition of endocytic pathways: Is it specific enough to be useful? In Exocytosis and Endocytosis, Ivanov, A., Ed. Humana Press: 2008; Vol. 440, pp 15-33.
70. Kim, H. J.; Ahn, H. S.; Choi, B. H.; Hahn, S. J. Inhibition of Kv4. 3 by genistein via a tyrosine phosphorylation-independent mechanism. Am. J. Physiol. Cell Physiol., 2011, 300, C567-C575.
71. Goluszko, P.; Nowicki, B. Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cells. Infect. Immun., 2005, 73, 7791-7796.
72. Parton, R.; Joggerst, B.; Simons, K. Regulated internalization of caveolae. J. Cell Biol., 1994, 127, 1199-1215.
73. Akiyama, T.; Ishida, J.; Nakagawa, S.; Ogawara, H.; Watanab, S.-i.; Itoh, N.; Shibuya, M.; Fukam, Y, Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem., 1987, 262, 5592-5595.
74. Thors, L.; Alajakku, K.; Fowler, C. J. The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake. Br. J. Pharmacol., 2007, 150, 951-960.
75. Cenedella, R. Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes. Lipids, 2009, 44, 477-487.
76. Juel, C. In: Encyclopedia of exercise medicine in health and disease, Mooren, F. C.; Skinner, J., Eds. Springer Berlin Heidelberg; 2012, 797-800.
77. Caperta, A. D.; Delgado, M.; Ressurreicao, F.; Meister, A.; Jones, R. N.; Viegas, W.; Houben, A. Colchicine-induced polyploidization depends on tubulin polymerization in c-metaphase cells. Protoplasma, 2006, 277, 147-153.
78. Orlowski, J.; Grinstein, S. Diversity of the mammalian sodium/proton exchanger SLC9 gene family. Pflügers Archiv., 2004, 447, 549-565.
79. Lamaze, C.; Fujimoto, L. M.; Yin, H. L.; Schmid, S. L. The actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells. J. Biol. Chem., 1997, 272, 20332-20335.
80. Naslavsky, N.; Weigert, R.; Donaldson, J. G. Convergence of nonclathrin-and clathrin-derived endosomes involves arf6 inactivation and changes in phosphoinositides. Mol. Biol. Cell., 2003, 14, 417-431.
81. Hansen, S. H.; Olsson, A.; Casanova, J. E. Wortmannin, an inhibitor of phosphoinositide 3-kinase, inhibits transcytosis in polarized epithelial cells. J. Biol. Chem., 1995, 270, 28425-28432.
82. Swiston, A. J.; Cheng, C.; Um, S. H.; Irvine, D. J.; Cohen, R. E.; Rubner, M. F. Surface functionalization of living cells with multilayer patches. Nano Lett., 2008, 8, 4446-4453.
83. Swiston, A. J.; Gilbert, J. B.; Irvine, D. J.; Cohen, R. E.; Rubner, M. F. Freely suspended cellular "backpacks" lead to cell aggregate self-assembly. Biomacromolecules, 2010, 11, 1826-1832.
84. Soma, C. E.; Dubernet, C.; Barratt, G.; Benita, S.; Couvreur, P., Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 cells in vitro. J. Control. Release, 2000, 68, 283-289.
85. Elamanchili, P.; Diwan, M.; Cao, M.; Samuel, J. Characterization of poly(d, l-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine, 2004, 22, 2406-2412.
86. Basu, M.; Lala, S. Macrophage specific drug delivery in experimental leishmaniasis. Curr. Mol. Med., 2004, 4, 681-689.
87. Schafer, V.; Briesen, H. v.; Andreesen, R.; Steffan, A.-M.; Royer, C.; Troster, S.; Kreuter, J.; Rubsamen-Waigmann, H. Phagocytosis of nanoparticles by human immunodeficiency virus (HlV)-infected macrophages: A possibility for antiviral drug targeting. Pharm. Res., 1992, 9, 541-546.
88. Luciani, N.; Gazeau, F.; Wilhelm, C. Reactivity of the monocyte/macrophage system to superparamagnetic anionic nanoparticles. J. Mater. Chem., 2009, 19, 6373-6380.
89. III, D. E. O.; Peppas, N. A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm., 2006, 307, 93-102.
90. Roser, M.; Fischer, D.; Kissel, T. Surface-modified biodegradable albumin nano-and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur. J. Pharm. Biopharm., 1998, 46(3), 255-263.
91. Chellat, F.; Grandjean-Laquerriere, A.; Naour, R. L.; Fernandes, J.; Yahia, L. H.; Guenounou, M.; Laurent-Maquin, D. Metalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticles. Biomaterials, 2005, 26 (9), 961-970.
92. Bastus, N. G.; Sanchez-Tillo, E.; Pujals, S.; Farrera, C.; Lopez, C.; Giralt, E.; Celada, A.; Lloberas, J.; Puntes, V. Homogeneous conjugation of peptides onto gold nanoparticles enhances macrophage response. ACS Nano, 2009, 3, 1335-1344.
93. Krpetić, Ž.; Porta, F.; Caneva, E.; Santo, V. D.; Scari, G. Phagocytosis of biocompatible gold nanoparticles. Langmuir, 2010, 26, 14799-14805.
94. Nishioka, K.; Constantopoulos, A.; Satoh, P. S.; Najjar, V. A. The characteristics, isolation and synthesis of the phagocytosis stimulating peptide tuftsin. Biochem. Biophys. Res. Commun., 1972, 47, 172-179.
95. Xu, Y.; Zhu, J.; Xiang, K.; Li, Y.; Sun, R.; Ma, J.; Sun, H.; Liu, Y. Synthesis and immunomodulatory activity of [60]fullerene-tuftsin conjugates. Biomaterials, 2011, 32, 9940-9949.
96. Jain, S.; Amiji, M., Tuftsin-modified alginate nanoparticles as a noncondensing macrophage-targeted DNA delivery system. Biomacromolecules, 2012, 13, 1074-1785.
97. Dutta, T.; Garg, M.; Jain, N. K. Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro. Eur. J. Pharm. Sci., 2008, 34, 181-189.
98. Brandhonneur, N.; Chevanne, F.; Vie, V.; Frisch, B.; Primault, R.; Potier, M.-F. L.; Corre, P. L. Specific and non-specific phagocytosis of ligand-grafted PLGA microspheres by macrophages. Eur. J. Pharm. Sci., 2009, 36, 474-485.
99. Horak, D.; Babič, M.; Jendelova, P.; Herynek, V.; Trchova, M.; Pientka, Z.; Pollert, M. H.; Sykova, E. d-Mannose-modified iron oxide nanoparticles for stem cell labeling. Bioconj. Chem., 2007, 18, 635-644.
100. Storm, G.; Belliot, S. O.; Daemen, T.; Lasic, D. D. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv. Drug Deliv. Rev., 1995, 17, 31-48.
101. Tyagi, R.; Lala, S.; Verma, A.; Nandy, A.; Mahato, S.; Maitra, A.; Basu, M. Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis. J. Drug Target, 2005, 13, 161-171.
102. Gaspar, R.; Opperdoes, F.; Preat, V.; Roland, M., Drug targeting with polyalkylcyanoacrylate nanoparticles: in vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani. Ann. Trop. Med. Parasitol., 1992, 86, 41-49.
103. Rodriguez, P. L.; Harada, T.; Christian, D. A.; Pantano, D. A.; Tsai, R. K.; Discher, D. E., Minimal "self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science, 2013, 339, 971-975.
104. Gref, R.; Luck, M.; Quellec, P.; Marchand, M.; Dellacherie, E.; Harnisch, S.; Blunk, T.; Muller, R., 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf. B., 2000, 18, 301-313.
105. Fontan, G.; Licciardi, M.; Mansueto, S.; Schillaci, D.; Giammona, G. Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: Influence of PEG coating on the particle size, drug release rate and phagocytic uptake. Biomaterials, 2001, 22, 2857-2865.
106. Gaucher, G.; Asahina, K.; Wang, J.; Leroux, J.-C. Effect of poly(nvinyl-pyrrolidone)-block-poly(d, l-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles. Biomacromolecules, 2009, 10, 408-416.
107. Yang, A.; Liu, W.; Li, Z.; Jiang, L.; Xu, H.; Yang, X. Influence of polyethyleneglycol modification on phagocytic uptake of polymeric nanoparticles mediated by immunoglobulin G and complement activation. J. Nanosci. Nanotechnol., 2010, 10, 622-628.
108. Liu, X.; Jin, Q.; Jia, Y.; Ji, J. Minimizing nonspecific phagocytic uptake of biocompatible gold nanoparticles with mixed charged zwitterionic surface modification. J. Mater. Chem., 2012, 22, 1916-1927.
109. Zahr, A. S.; Davis, C. A.; Pishko, M. V. Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). Langmuir, 2006, 22, 8178-8185.
110. Davda, J.; Labhasetwar, V. Characterization of nanoparticle uptake by endothelial cells. Int. J. Pharm., 2002, 233, 51-59.
111. Qaddoumi, M. G.; Gukasyan, H. J.; Davda, J.; Labhasetwar, V.; Kim, K.-J.; Lee, V. H. L. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: Role in PLGA nanoparticle endocytosis. Mol. Vision, 2003, 9, 59-68.
112. Harush-Frenkel, O.; Debotton, N.; Benita, S.; Altschuler, Y. Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochem. Biophys. Res. Commun., 2007, 353, 26-32.
113. Vasir, J. K.; Labhasetwar, V. Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles. Biomaterials, 2008, 29, 4244-4252.
114. Ma, Z.; Lim, L. Uptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles. Pharm. Res., 2003, 20, 1812-1821.
115. Chung, T.; Wu, S.; Yao, M.; Lu, C.; Lin, Y.; Hung, Y.; Mou, C.; Chen, Y.; Huang, D., The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials, 2007, 28, 2959-2966.
116. Hu, Z.; Pan, Y.; Wang, J.; Chen, J.; Li, J.; Ren, L. Meso-tetra (carboxyphenyl) porphyrin (TCPP) nanoparticles were internalized by SW480 cells by a clathrin-mediated endocytosis pathway to induce high photocytotoxicity. Biomed. Pharmacother., 2009, 63, 155-164.
117. Xiao, G.; Gan, L.-S. Receptor-mediated endocytosis and brain delivery of therapeutic biologics. Int. J. Cell Biol., 2013, 70, 3545.
118. Rejman, J.; Oberle, V.; Zuhorn, I. S.; Hoekstra, D. Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem. J., 2004, 377, 159-169.
119. Tahara, K.; Sakai, T.; Yamamoto, H.; Takeuchi, H.; Hirashima, N.; Kawashima, Y. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells. Int. J. Pharm., 2009, 382, 198-204.
120. Chaudhary, S.; Smith, C. A.; Pino, P. d.; Fuente, J. M. d. l.; Mullin, M.; Hursthouse, A.; Stirling, D.; Berry, C. C. Elucidating the function of penetratin and a static magnetic field in cellular uptake of magnetic nanoparticles. Pharmaceuticals, 2013, 6, 204-222.
121. Biju, V.; Itoh, T.; Anas, A.; Sujith, A.; Ishikawa, M. Semiconductor quantum dots and metal nanoparticles: Syntheses, optical properties, and biological applications. Anal. Bioanal. Chem., 2008, 391, 2469-2495.
122. Yezhelyev, M. V.; Qi, L. F.; O'Regan, R. M.; Nie, S.; Gao, X. H. Proton-sponge coated quantum dots for sirna delivery and intracellular imaging. J. Am. Chem. Soc., 2008, 130, 9006-9012.
123. Anas, A.; Okuda, T.; Kawashima, N.; Nakayama, K.; Itoh, T.; Ishikawa, M.; Biju, V. Clathrin-mediated endocytosis of quantum dot-peptide conjugates in living cells. ACS Nano, 2009, 3, 2419-2429.
124. Wang, G.; Norton, A. S.; Pokharel, D.; Song, Y.; Hill, R. A. KDEL peptide gold nanoconstructs: promising nanoplatforms for drug delivery. Nanomed. Nanotechnol. Biol. Med., 2013, 9, 366-374.
125. Bareford, L. M.; Phelps, M. A.; Foraker, A. B.; Swaan, P. W. Intracellular processing of riboflavin in human breast cancer cells. Mol. Pharmacol., 2008, 5, 839-848.
126. Li, Y.-q.; Zhou, X.-p. Transferrin-coupled fluorescence nanodiamonds as targeting intracellular transporters: An investigation of the uptake mechanism. Diamond Relat. Mater., 2010, 19, 1163-1167.
127. Wang, J.; Tian, S.; Petros, R. A.; Napier, M. E.; DeSimone, J. M. The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies. J. Am. Chem. Soc., 2010, 132, 11306-11313.
128. Tsuji, T.; Yoshitomi, H.; Usukura, J., Endocytic mechanism of transferrin-conjugated nanoparticles and the effects of their size and ligand number on the efficiency of drug delivery. Microscopy (Oxf), 2013, 62, 341-352.
129. Chang, J.; Jallouli, Y.; Kroubi, M.; Yuan, X.-b.; Feng, W.; Kang, C.-s.; Pu, P.-y.; Betbeder, D. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier. Int. J. Pharm., 2009, 379, 285-292.
130. Mason, C. W.; D'Souza, V. M.; Bareford, L. M.; Phelps, M. A.; Ray, A.; Swaan, P. W. Recognition, co-internalization, and recycling of an avian riboflavin carrier protein in human placental trophoblasts. J. Pharmacol. Exp. Ther., 2006, 317, 465-472.
131. Jayapaul, J.; Arns, S.; Lederle, W.; Lammers, T.; Comba, P.; Gatjens, J.; Kiessling, F. Riboflavin carrier protein-targeted fluorescent USPIO for the assessment of vascular metabolism in tumors. Biomaterials, 2012, 33, 8822-8829.
132. Thomas, T. P.; Choi, S. K.; Li, M.-H.; Kotlyar, A.; Baker, J. R. Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery. Bioorg. Med. Chem. Lett., 2010, 20, 5191-5194.
133. Witte, A. B.; Timmer, C. M.; Gam, J. J.; Choi, S. K.; Holl, M. M. B.; Orr, B. G.; Baker., J. R.; Sinniah, K. Biophysical characterization of a riboflavin-conjugated dendrimer platform for targeted drug delivery. Biomacromolecules, 2012, 13, 507-516.
134. Corbin, I. R.; Li, H.; Chen, J.; Lund-Katz, S.; Zhou, R.; Glickson, J. D.; Zheng, G. Low-Density Lipoprotein Nanoparticles as Magnetic Resonance Imaging Contrast Agents. Neoplasia, 2006, 8, 488-498.
135. Conner, S. D.; Schmid, S. L. Regulated portals of entry into the cell. Nature, 2003, 442, 37-44.
136. Gabizon, A.; Shmeeda, H.; Horowitz, A. T.; Zalipsky, S. Tumor cell targeting of liposome-entrapped drugs with phospholipidanchored folic acid-PEG conjugates. Adv. Drug Deliv. Rev. 2004, 56, 1177-1192.
137. Franzen, S. A comparison of peptide and folate receptor targeting of cancer cells: from single agent to nanoparticle. Expert. Opin. Drug Deliv., 2011, 8, 281-298.
138. Hattori, Y.; Maitani, Y. Folate-linked lipid-based nanoparticle for targeted gene delivery. Curr. Drug Deliv., 2005, 2, 243-252.
139. Aronov, O.; Horowitz, A. T.; Gabizon, A.; Gibson, D. Folatetargeted peg as a potential carrier for carboplatin analogs. Synthesis and in vitro studies. Bioconj. Chem., 2003, 14, 563-574.
140. Kim, S. H.; Jeong, J. H.; Joe, C. O.; Park, T. G. Folate receptor mediated intracellular protein delivery using PLL-PEG-FOL conjugate. J. Control. Release, 2005, 103, 625-634.
141. Kang, B.; Yu, D.-c.; Chang, S.-q.; Chen, D.; Dai, Y.-d.; Ding, Y. Intracellular uptake, trafficking and subcellular distribution of folate conjugated single walled carbon nanotubes within living cells. Nanotechnology, 2008, 19, 375103.
142. Rajjayabun, P.; Garg, S.; Durkan, G.; Charlton, R.; Robinson, M.; Mellon, J., Caveolin-1 expression is associated with high-grade bladder cancer. Urology, 2001, 58, 811-814.
143. Lavie, Y.; Fiucci, G.; Liscovitch, M. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J. Biol. Chem., 1998, 273, 32380-32383.
144. Kibria, G.; Hatakeyama, H.; Ohga, N.; Hida, K.; Harashima, H. Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery. J. Control. Release, 2011, 153, 141-148.
145. Fang, I.-J.; Slowing, I. I.; Wu, K. C.-W.; Lin, V. S.-Y.; Trewyn, B. G. Ligand conformation dictates membrane and endosomal trafficking of arginine-glycine-aspartate (rgd)-functionalized mesoporous silica nanoparticles. Chem. Eur. J., 2012, 18, 7787-7792.
146. Liu, P.; Qin, L.; Wang, Q.; Sun, Y.; Zhu, M.; Shen, M.; Duan, Y. cRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancer. Biomaterials, 2012, 33, 6739-6747.
147. Hawkins, M. J.; Soon-Shiong, P.; Desai, N. Protein nanoparticles as drug carriers in clinical medicine. Adv. Drug Deliv. Rev., 2008, 60, 876-885.
148. Wang, Z.; Tiruppathi, C.; Minshall, R. D.; Malik, A. B., Size and dynamics of caveolae studied using nanoparticles in living endothelial cells. ACS Nano, 2009, 3, 4110-4116.
149. Wang, Z.; Malik, A. B. Nanoparticles squeezing across the bloodendothelial barrier via caveolae. Ther. Deliv., 2013, 4, 131-133.
150. Lu, W.; Wan, J.; She, Z.; Jiang, X. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle. J. Control. Release, 2007, 118, 38-53.
151. Lu, W.; Zhang, Y.; Tan, Y.-Z.; Hu, K.-L.; Jiang, X.-G.; Fu, S., K. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J. Control. Release, 2005, 107, 428-448.
152. Islam, M. A.; Shin, J.-Y.; Firdous, J.; Park, T.-E.; Choi, Y.-J.; Cho, M.-H.; Yun, C.-H.; Cho, C.-S., The role of osmotic polysorbitolbased transporter in RNAi silencing via caveolae-mediated endocytosis and COX-2 expression. Biomaterials, 2012, 33, 8868-8880.
153. Bronich, T. K.; Keifer, P. A.; Shlyakhtenko, L. S.; Kabanov, A. V. Polymer micelle with cross-linked ionic core. J. Am. Chem. Soc.,. 2005, 127, 8236-8237.
154. Sahay, G.; Kim, J. O.; Kabanov, A. V.; Bronich, T. K. The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents. Biomaterials, 2010, 31, 923-933.
155. Voigt, J.; Christensen, J.; Shastri, V. P. Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae. Proc. Natl. Acad. Sci. U. S. A., 2014, 111, 2942-2947.
156. Mudhakir, D.; Akita, H.; Tan, E.; Harashima, H. A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway. J. Control. Release, 2008, 125, 164-173.
157. Mudhakir, D.; Tan, E.; Akita, H.; Harashima, H. In An improvement delivery of siRNA by irq ligand-modified double membranous nanocarrier, AIP Conf. Proc., Bandung, (Indonesia), AIP publisher: Bandung, (Indonesia), 2010; pp 199-202.
158. Oh, P.; Borgstrom, P.; Witkiewicz, H.; Li, Y.; Borgstrom, B. J.; Chrastina, A.; Iwata, K.; Zinn, K. R.; Baldwin, R.; Testa, J. E.; Schnitzer, J. E. Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat. Biotechnol., 2007, 25, 327-337.
159. Wennerberg, K.; Der, C. J., Rho-family GTPases: it's not only Rac and Rho (and I like it). J. Cell Sci., 2004, 117(8), 1301-1312.
160. Dhaliwal, A.; Maldonado, M.; Lin, C.; Segura, T., Cellular cytoskeleton dynamics modulates non-viral gene delivery through rhogtpases. PLoS ONE, 2012, 7(4), e35046.
161. Vercauteren, D.; Piest, M.; Aa, L. J. v. d.; Soraj, M. A.; Jones, A. T.; Engbersen, J. F. J.; Smedt, S. C. D.; Braeckmans, K., Flotillindependent endocytosis and a phagocytosis-like mechanism for cellular internalization of disulfide-based poly(amido amine)/DNA polyplexes. Biomaterials, 2011, 32, 3072-3084.
162. Contreras, J.; Xie, J.; Chen, Y. J.; Pei, H.; Zhang, G.; Fraser, C. L.; Hamm-Alvarez, S. F. Intracellular uptake and trafficking of difluoroboron dibenzoylmethane-polylactide nanoparticles in hela cells. ACS Nano., 2010, 4, 2735-2747.
163. Xu, Y.; Liu, B. R.; Lee, H.-J.; Shannon, K. B.; Winiarz, J. G.; Wang, T.-C.; Chiang, H.-J.; Huang, Y.-w., Nona-arginine facilitates delivery of quantum dots into cells via multiple pathways. J. Biomed. Biotechnol., 2010, 2010, 948543.
164. Choi, C.; Hao, L.; Narayan, S.; Auyeung, E.; Mirkin, C. Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates. Proc. Natl. Acad. Sci. U. S. A., 2013, 110, 7625-2630.
165. Khalil, I. A.; Kogure, K.; Futaki, S.; Hama, S.; Akita, H.; Ueno, M.; Kishida, H.; Kudoh, M.; Mishina, Y.; Kataoka, K.; Yamada, M.; Harashima, H. Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery. Gene Ther., 2007, 14, 682-689.
166. Pritz, C. O.; Bitsche, M.; Salvenmoser, W.; Dudas, J.; Schrott-Fischer, A.; Glueckert, R. Endocytic trafficking of silica nanoparticles in a cell line derived from the organ of Corti. Nanomedicine, 2013, 8, 239-252.
167. Vollrath, A.; Schallon, A.; Christian Pietsch; Schubert, S.; Nomoto, T.; Matsumoto, Y.; Kataoka, K.; Schubert, U. S. A toolbox of differently sized and labeled PMMA nanoparticles for cellular uptake investigations. Soft Matter., 2013, 9, 99-108.
168. Sawant, R. M.; Hurley, J. P.; Salmaso, S.; Kale, A.; Tolcheva, E.; Levchenko, T. S.; Torchilin, V. P. "Smart" drug delivery systems: Double-targeted pH-responsive pharmaceutical nanocarriers. Bioconj. Chem., 2006, 17, 943-949.
169. Khalil, I. A.; Kogure, K.; Futaki, S.; Harashima, H. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J. Biol. Chem., 2006, 281(6), 3544-3551.
170. Iversen, T. G.; Frerker, N.; Sandvig, K., Uptake of ricinB-quantum dot nanoparticles by a macropinocytosis-like mechanism. J. Nanobiotechnol., 2012, 10, 33.
171. Beck, M. Therapy for lysosomal storage disorders. IUBMB Life 2010, 6, 33-40.
172. Davis, M. E.; Zuckerman, J. E.; Choi, C. H., Seligson, D.; Tolcher, A.; Alabi, C. A.; Yen, Y., Heidel, J. D.; Ribas, A. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature, 2010, 464, 1067-1070.
173. Pack, D. W.; Hoffman, A. S.; Pun, S.; Stayton, P. S. Design and development of polymers for gene delivery. Nat. Rev. Drug Discov., 2005, 4, 581-593.
174. Behr, J.-P. The proton sponge: a trick to enter cells the viruses did not exploit. Chimia, 1997, 51(1-2), 34-36.
175. Benjaminsen, R.; Mattebjerg, M.; Henriksen, J.; Moghimi, S.; Andresen, T. The possible "proton sponge" effect of polyethylenimine (PEI) does not include change in lysosomal pH. Mol. Ther., 2013, 21, 149-157.
176. Ikonen, E. Cellular cholesterol trafficking and compartmentalization. Nat. Rev. Mol. Cell Biol., 2008, 9, 125-138.
177. Xu, Y.; Szoka, F. J., Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry, 1996, 35, 5616-5623.
178. Liang, W.; Lam, J. K. W.; In: Molecular Regulation of Endocytosis; Ceresa, B., Ed.; Intech, 2012, pp 429-459.
179. Hu, Y.; Litwin, T.; Nagaraja, A. R.; Kwong, B.; Katz, J.; Watson, N.; Irvine, D. J. Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles. Nano Lett., 2007, 7, 3056-3064.
180. Panyam, J.; Zhou, W.-Z.; Prabha, S.; Sahoo, S. K.; Labhasetwar, V., Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J., 2002, 16, 1217-1226.
181. Kunisawa, J.; Masuda, T.; Katayama, K.; Yoshikawa, T.; Tsutsumi, Y.; Akashi, M.; Mayumi, T.; Nakagawa, S. Fusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene release. J. Control. Release, 2005, 105, 344-353.
182. Jana, S. S.; Bharali, D. J.; Mani, P.; Maitra, A.; Gupta, C. M.; Sarkar, D. P. Targeted cytosolic delivery of hydrogel nanoparticles into HepG2 cells through engineered Sendai viral envelopes. FEBS Lett., 2002, 515, 184-188.
183. Mastrobattista, E.; Koning, G. A.; Bloois, L. v.; Filipe, A. C. S.; Jiskoot, W.; Storm, G. Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins. J. Biol. Chem. 2002, 277, 27135-27143.
184. Berg, K.; Selbo, P. K.; Prasmickaite, L.; Tjelle, T. E.; Sandvig, K.; Moan, J.; Gaudernack, G.; Fodstad, O.; Kjolsrud, S.; Anholt, H.; Rodal, G. H.; Rodal, S. K.; Hogset, A. Photochemical internalization a novel technology for delivery of macromolecules into cytosol. Cancer Res., 1999, 59, 1180-1183.
185. Febvay, S.; Marini, D. M.; Belcher, A. M.; Clapham, D. E. Targeted cytosolic delivery of cell-impermeable compounds by nanoparticle-mediated, light-triggered endosome disruption. Nano Lett., 2010, 10, 2211-2219.
186. Tran, T. D.; Caruthers, S. D.; Hughes, M.; Marsh, J. N.; Cyrus, T.; Winter, P. M.; Neubauer, A. M.; Wickline, S. A.; Lanza, G. M. Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics. Int. J. Nanomed., 2007, 2, 515-526.
187. Partlow, K. C.; Lanza, G. M.; Wickline, S. A. Exploiting lipid raft transport with membrane targeted nanoparticles: A strategy for cytosolic drug delivery. Biomaterials, 2008, 29, 3367-3375.
188. Yang, M.; Jin, H.; Chen, J.; Ding, L.; Ng, K. K.; Lin, Q.; Lovell, J. F.; Zhang, Z.; Zheng, G. Efficient cytosolic delivery of siRNA using HDL-mimicking nanoparticles. Small, 2011, 7, 568-573.
189. Pouton, C. W.; Wagstaff, K. M.; Roth, D. M.; Moseley, G. W.; Jans, D. A. Targeted delivery to the nucleus. Adv. Drug Deliv. Rev., 2007, 59, 698-717.
190. Wangemail, R.; Brattainemail, M. G., The maximal size of protein to diffuse through the nuclear pore is larger than 60kDa. FEBS Lett. 2007, 581(17), 3164-3170.
191. Gu, Y.-J.; Cheng, J.; Lin, C.-C.; Lam, Y. W.; Cheng, S. H.; Wong, W.-T. Nuclear penetration of surface functionalized gold nanoparticles. Toxicol. Appl. Pharmacol., 2009, 237, 196-204.
192. Rhee, M.; Davis, P. Mechanism of uptake of c105y, a novel cellpenetrating peptide. J. Biol. Chem., 2006, 281, 1233-1240.
193. Freitas, N.; Cunha, C. Mechanisms and signals for the nuclear import of proteins. Curr. Genom., 2009, 10, 550-557.
194. Pante, N.; Kann, M. Nuclear pore complex is able to transport macromolecules with diameters of 39 nm. Mol. Biol. Cell., 2002, 13, 425-434.
195. Chan, C.; Senden, T.; Jans, D. Supramolecular structure and nuclear targeting efficiency determine the enhancement of transfection by modified polylysines. Gene Ther., 2000, 7, 1690-1697.
196. Pan, L.; He, Q.; Liu, J.; Chen, Y.; Ma, M.; Zhang, L.; Shi, J. Nuclear-targeted drug delivery of tat peptide-conjugated monodisperse mesoporous silica nanoparticles. J. Am. Chem. Soc. 2012, 134, 5722-5725.
197. Jana, A.; Saha, B.; Banerjee, D. R.; Ghosh, S. K.; Nguyen, K. T.; Ma, X.; Qu, Q.; Zhao, Y.; Singh, N. D. P. Photocontrolled nucleartargeted drug delivery by single component photoresponsive fluorescent organic nanoparticles of acridin-9-methanol. Bioconj. Chem., 2013, 24, 1828-1839.
198. Belting, M.; Sandgren, S.; Wittrup, A. Nuclear delivery of macromolecules: barriers and carriers. Adv. Drug Deliv. Rev., 2005, 57, 505-527.
199. Escoffre, J.-M.; Teissie, J.; Rols, M.-P. Gene transfer: How can the biological barriers be overcome? J. Membr. Biol., 2010, 236, 61-74.
200. Sui, M.; Liu, W.; Shen, Y. Nuclear drug delivery for cancer chemotherapy. J. Control. Release, 2011, 155, 227-236.
201. Branden, L.; Mohamed, A.; Smith, C. A peptide nucleic acidnuclear localization signal fusion that mediates nuclear transport of DNA. Nat. Biotechnol., 1999, 17, 784-787.